Drugs / emtricitabine/tenofovir disoproxil fumarate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00711009 Comparator | Jul 2008 → Nov 2009 | HIV infectious disease | Abbott | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | emtricitabine/tenofovir disoproxil fumarate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00711009 ↗ |
| Action | Inhibit | “2 nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)” PMID 22180523 ↗ Sep 2011 |